IL-1 beta Protein
Kurzübersicht für IL-1 beta Protein (ABIN7849736)
Target
Alle IL-1 beta (IL1B) Proteine anzeigenProtein-Typ
Spezies
Quelle
Applikation
Reinheit
-
-
Verwendungszweck
- Recombinant Human Interleukin-1beta, IL1B Protein
-
Endotoxin-Niveau
- < 0.1 ng/μg (1 EU/μg) by LAL test
-
-
Möchten Sie weitere Optionen für dieses Protein ?
!Entdecken Sie unsere vordefinierten maßgeschneiderten Proteine und Proteinservices!Ihr Projekt erfordert weitere Anpassungen? Kontaktieren Sie uns und entdecken Sie unsere maßgeschneiderten Proteinlösungen
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Buffer
- Lyophilized,Each vial contains 10 mM Phosphate bufferand 200 mM NaCl( pH 7.0) without preservatives.
-
Konservierungsmittel
- Without preservative
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Ship at 4°C. Upon receipt,store at -20°C for long term. Avoid repeated freeze and thaw cycles.
-
-
- IL-1 beta (IL1B) (Interleukin 1, beta (IL1B))
-
Andere Bezeichnung
- IL1B
-
Hintergrund
-
Synonyms: Interleukin-1 beta, IL1B, IL-1 beta, Catabolin, IL1F2, IL-1B, IL-1, IL1-BETA, IL1F2, interleukin 1 beta.
Description: Recombinant human IL-1 beta protein.
Background: Interleukin-1β (IL-1β) is a potent stimulator of bone resorption whose gene is mapped to 2q14, and has been implicated in the pathogenesis of high bone turnover and osteoporosis. It can reset glucose homeostasis at central levels. It cause oligodendrocyte death in coculture with astrocytes and microglia, and also can cause nuclear export of a specific NCOR corepressor complex, resulting in derepression of a specific subset of nuclear factor-kappa-B (NFKB)-regulated genes. Pathak et al. (2011) proposed that IL1B blockade may be a viable therapy for patients with autoimmune inner ear disease or sensorineural hearing loss that fail to respond to corticosteroids.
-
Pathways
- NF-kappaB Signalweg, Interferon-gamma Pathway, TLR Signalweg, Negative Regulation of Hormone Secretion, Cellular Response to Molecule of Bacterial Origin, Carbohydrate Homeostasis, Glycosaminoglycan Metabolic Process, Myometrial Relaxation and Contraction, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Autophagie, Cancer Immune Checkpoints, Inflammasome
Target
-